Introduction
============

Obesity is becoming more common^[@bib1]^ and with it, so are diseases such as type 2 diabetes mellitus (DM),^[@bib2],\ [@bib3]^ hypertension^[@bib3],\ [@bib4]^ and hypercholesterolemia.^[@bib3]^ Although increased body fat has an impact on health, body fat distribution, particularly fat stored in the visceral adipose tissue (VAT), is also important. VAT has been shown to be an independent risk factor for coronary heart disease,^[@bib5]^ hypertension,^[@bib6]^ DM^[@bib7]^ and impaired glucose tolerance.^[@bib8]^ VAT, but not subcutaneous adipose tissue, is correlated with intrahepatic fat and insulin resistance.^[@bib9]^

The best way to assess VAT is not clear. In clinical practice, the waist circumference (WC) has been recommended as a marker for VAT.^[@bib10]^ However, the relationship between WC and VAT varies between the ethnic groups. Japanese men had larger areas of VAT than Caucasians at the same levels of WC.^[@bib11]^ The same is true of Filipinas compared with Caucasian women.^[@bib12]^ An alternative means for assessing VAT (usually used in a research setting) is to use computed tomography (CT) or magnetic resonance imaging, but the utility of these modalities is limited by the amount of radiation exposure for CT and the high cost for magnetic resonance imaging. Therefore, most investigators used a single cross-sectional image as a representative measure of VAT volume as a compromise between accuracy and cost in their research. The VAT area at L4-L5 intervertebral space is usually the level used to estimate total VAT volume.^[@bib13]^ Although the VAT area at L4-L5 intervertebral space has been used in studies conducted in Korean, Asian Indian and Chinese populations,^[@bib14],\ [@bib15],\ [@bib16]^ it is not known whether that is indeed the best level at which to assess VAT in these populations. In fact, some recent studies had found the VAT area at L2-L3 intervertebral space to be more representative of total VAT in the Caucasian population.^[@bib13],\ [@bib17],\ [@bib18]^

We set out to (1) identify the level of intervertebral space on CT that best approximates total VAT volume; (2) compare the association between WC and VAT in Chinese and Asian Indian men living in Singapore; and (3) examine the correlation between VAT and features of the metabolic syndrome, as well as selected inflammatory markers and adipokines in Chinese and Indian men living in Singapore.

Materials and methods
=====================

Institutional Review Board approval was obtained at the site. A total of 60 Chinese and 60 Indian men over the age of 60 were recruited. These subjects were primarily recruited from community-based health check fairs. We specifically recruited male subjects aged 60 years and above as they were more likely to have a higher cardiovascular burden. Informed consent was taken from the subjects. Where possible, we recruited healthy subjects who were not on medication for hypertension, hypercholesterolemia or diabetes. This proved to be harder for the Asian Indians and we ended up recruiting some who were on these medications. This is consistent with the previously published data that has shown a higher prevalence of diabetes, hypertension and dyslipidemia among Asian Indians compared with the Chinese.^[@bib19],\ [@bib20]^ We excluded those with known Cushing\'s syndrome, previous abdominal surgery, previous malignancies and those who were on antiviral medications, weight loss medications, corticosteroids, previous abdominal surgery or any investigational drugs for the past 3 months and those had excessive weight loss (\>5% body weight) over the past 3 months.

A detailed medical history was obtained through interviewing the subjects. These included information on smoking habits, alcohol ingestion, exercise frequency and the presence of DM, hypertension, hypercholesterolemia and ischemic heart disease. Family history of diabetes and hypertension were documented.

Height (to the nearest millimeter) was recorded in all subjects without shoes, and weight (in kilograms) was measured with subjects in light clothing using electronic weighing scales (seca 220 - seca deutschland, Hamburg, Germany). Body mass index (BMI) was computed using weight divided by the square of the height (kilograms per meter squared). WC was measured once at the midpoint between the costal margin and the iliac crest in the mid-clavicular line by a single trained technician. Hip circumference was measured at the level of the greater trochanter of the femur. The waist--hip ratio was computed as waist circumference divided by hip circumference. At least two readings of blood pressure (BP) were taken from subjects who had rested adequately before measurement, using a standard mercury sphygmomanometer. If the two readings differed by more than diastolic 5 mm Hg or systolic 10 mm Hg, a third reading was obtained. The mean value of the two closest readings was calculated and recorded as the subject\'s BP.

Fasting blood specimens for lipids, insulin (10 ml plain tubes) and glucose (2 ml fluoride oxalate tubes) were taken from all subjects after an overnight fast of 10 h. Plasma glucose was measured by the glucose oxidase method with an interassay CV of 3.3% (Beckman Coulter, Inc., Brea, CA, USA). Total cholesterol, high-density lipoprotein cholesterol (HDL-c) and triglyceride (TG) were measured by the 1-step immunoenzymatic assay with an interassay CV of between 1.6 and 1.7% (Beckman). Low-density lipoprotein cholesterol (LDL-c) was calculated by Friedewald\'s equation. Insulin resistance was evaluated by homeostasis model assessment-insulin resistance (HOMA-IR)^[@bib21]^ using the formula: fasting serum insulin (μU ml^−1^) × fasting plasma glucose (mmol l^−1^)/22.5.

The adipokines leptin, resistin and adiponectin were measured using commercially available kits (Linco Research, Inc., St Charles, MO, USA). High-sensitivity C-reactive protein was measured using a highly sensitive near infrared particle immunoassay rate technology with intra- and interassay CV 1.3% and 4.1%, respectively (Beckman Coulter, Inc.). Interleukin-6 was measured by ELISA using commercially available kits Linco Research, Inc.

Abdominal CT
------------

Abdominopelvic VAT was determined using a 64-slice multi-detector CT scanner (Somatom Definition, Siemens AG, Erlangen, Germany). Axial CT scan was performed with the subjects supine, from the dome of the diaphragm down to the bottom of the pelvis, using a 35 × 35-cm field of view. Non-contrast enhanced scans using routine scan parameters of kVp (120); effective mAs (210); slice collimation 0.6 mm; slice width 5.0 mm; pitch factor 1.4 and increment 5.0 mm were acquired. The thin-slice raw data was reconstructed into 1 mm sections at zero gap intervals.

All image analyses were performed by a single research assistant, under the guidance of the radiologist. The 3D CT image data sets were transferred to a PC workstation and volumes were measured using the commercial image analysis software, Analyze 9.0 (AnalyzeDirect, Inc., Overland Park, KS, USA).

Fat appears as areas of lower density on the CT images and was identified as areas of attenuation values of −195 to −45 Hounsfield units according to standardized protocol.^[@bib22]^ The abdominopelvic VAT was defined as the area of adipose tissue within the inside edge of the abdominal wall, as proposed by Shen *et al.*^[@bib23]^ All images were then checked and manually edited to ensure that fecal matter and bowel gas within the bowels were excluded from the volumetric analysis.

The cross-sectional VAT area at the seven intervertebral disk levels of T11/12, T12/L1, L1/2, L2/3, L3/4, L4/5 and L5/S1, and the total VAT volume at these levels in 22 randomly chosen subjects (11 Chinese and 11 Indians) were measured to determine which level was most representative of the total VAT volume. There were no differences in background characteristics between subjects who were chosen and those who were not chosen for this total VAT volume analysis. Subsequent analyses used only the VAT at the level which was most representative of total VAT volume and at the traditional L4/5 level for the full cohort of 120 subjects.

In addition, the cross-sectional VAT area at L2/3 was subdivided into intraperitoneal (IP) and retroperitoneal (RP) adipose tissue (AT). The areas of IP-AT and RP-AT were quantified by using a method similar to that of Baumgartner *et al.*,^[@bib24]^ namely by drawing two diagonal lines from the anterior edge of the aorta and inferior vena cava tangentially across the anterior border of each kidney to their intersection with the line circumscribing the VAT area. RP-AT was defined as the VAT posterior to that line, and IP-AT was defined as the VAT anterior to it.

Statistical analysis
--------------------

Statistical analysis was done using SPSS 11.0 (SPSS Inc., Chicago, IL, USA). Student\'s *t*-test and the Mann--Whitney test were used to compare the means of normally and non-normally distributed parameters, respectively. Pearson correlation coefficients were computed to assess the relationship between VAT and WC in each ethnic group and the associations compared between ethnic groups. For hypertensive subjects with hypertension, we adjusted for antihypertensive medication use by adding a constant to the observed BP measurements, 10 mm Hg to systolic BP and 5 mm Hg to diastolic BP. This approach was suggested by Cui *et al.*^[@bib25]^ and later validated by Tobin *et al.*^[@bib26]^ Nineteen subjects who were on diabetic medication were excluded from the analysis of fasting glucose and insulin. Twenty subjects who were on lipid medication were excluded from the analysis of fasting lipids. Parameters that were not normally distributed underwent logarithmic transformation. Pearson\'s Correlations between VAT and WC and clinical and biochemical parameters were analyzed.

Multivariable regression using general linear models was performed separately for each ethnic group to assess the relationship between VAT and features of the metabolic syndrome. A regression model that included ethnicity, VAT and an ethnicity × VAT interaction term was used to determine whether the relationship between VAT and features of the metabolic syndrome differed by ethnicity.

Results
=======

[Table 1](#tbl1){ref-type="table"} shows the characteristics of our subjects. Subjects from the two groups were clinically similar. Any differences in height, weight, BMI, WC and L2/3 VAT area were not statistically significant. However, while the Chinese men were generally healthy, about two thirds of the Indian men had hypertension, one third had diabetes and one third had hypercholesterolemia. Despite the similarity in weight, WC and BMI, leptin and hs-CRP levels were higher in Asian Indians, whereas resistin levels were lower and adiponectin levels were similar.

In 22 randomly selected subjects, we found that the L2/3 VAT area correlated almost perfectly with total VAT volume with *r*^2^ that is close to unity for both Chinese and Indian men ([Table 2](#tbl2){ref-type="table"}). The degree of correlation was much better than that for L4/5 VAT area and VAT volume (*R*^2^=0.974 and 0.946 for Chinese and Asian Indians, respectively).

WC was correlated with the L2/3 VAT area in both Chinese (*r*=0.484, *P*\<0.001) and Indian subjects (*r*=0.366, *P*=0.004; [Figure 1](#fig1){ref-type="fig"}). Thus, WC explained 23 and 13% of the variance of VAT area at L2/3. There was no significant difference between the two races, with *P*=0.2 for the interaction term race × WC. However, when we divided the VAT into IP-AT and RP-AT, some ethnic differences were observed. In both the ethnic groups, WC correlated with IP-AT in a similar manner (*P*-interaction=0.5, [Figure 2](#fig2){ref-type="fig"}), but increasing WC was associated with a greater increased in RP-AT in Chinese than in Indians (*P*-interaction 0.036, [Figure 3](#fig3){ref-type="fig"}). At low WC, Chinese men had lower RP-AT than Indian men; however, at high WC, Chinese men had higher RP-AT.

To further evaluate the biological relevance of the L2/3 VAT area compared with the L4/5 VAT area and WC, we examined the correlation between the VAT area at each level with CVD risk factors, the adipokines leptin and adiponectin, and the inflammatory marker hs-CRP, after correction for age and race ([Table 3](#tbl3){ref-type="table"}). The L2/3 VAT area showed a stronger correlation with virtually all the parameters. The correlations after additional adjustment for BMI remained statistically significant for L2/3 VAT for fasting glucose, fasting insulin, HOMA-IR, HDL-c, TG, leptin and adiponectin. In contrast, WC showed statistically significant associations only for fasting insulin, HOMA-IR, HDL-c and TG, and only TG remained statistically significant after further adjustment for BMI.

We then compared the correlations between IP-AT and RP-AT with CVD risk factors and inflammatory markers ([Table 4](#tbl4){ref-type="table"}). Both IP-AT and RP-AT were correlated with multiple metabolic traits both before and after adjustment for BMI. However, when both IP-AT and RP-AT were incorporated into the same model, only fasting insulin was correlated with RP-AT, whereas correlations for fasting glucose, HOMA-IR and TG remained statistically significant for IP-AT.

Discussion
==========

In this study, CT-based measures of VAT was more strongly correlated to metabolic parameters than WC, which is in line with the belief that VAT is an important fat depot in the pathogenesis of DM and CVD. Furthermore, WC was a rather poor measure of VAT in Chinese and Asian Indian men, explaining only 23% and 13% of the variance of VAT area, respectively, as compared with 60% in Caucasian men.^[@bib27]^ In fact, the proportion of variance of VAT explained by WC was lower in our study than in other Asian populations. Based on previous studies, the variance of VAT area that was explained by WC was 33% in Indian men,^[@bib15]^ 39% in Japanese men,^[@bib28]^ 29% in Korean women,^[@bib29]^ 35% in Filipino American women^[@bib30]^ and 54 to 56% in Japanese women.^[@bib28],\ [@bib31]^ We were unable to find any reported value of Chinese populations.

We also found that in Chinese and Asian Indian men, VAT at the L2/3 level was more strongly correlated to both total VAT volume as well as most clinical and laboratory markers for CVD than the VAT at L4/5, which is used most commonly for the assessment of visceral adiposity. These findings are in line with more recent studies in Caucasian populations that have shown the L2/3 VAT better represented visceral adiposity.^[@bib13],\ [@bib17],\ [@bib18],\ [@bib32]^ Further, in a study by Kuk *et al.*^[@bib32]^ involving 85 Caucasian men of mean age about 50 years, the odds ratio (OR, per s.d.) for the metabolic syndrome based on the National Cholesterol Education Program (NCEP) criteria was much higher for the VAT at L1-L2 level (8.77) than at the L4-L5 level (3.94).

In our study, there was no significant difference of the relationship between WC and VAT between Chinese and Asian Indian men. In both races, the VAT increases as the WC increases. Several guidelines have suggested that we should use the same cutoff to define central obesity in Chinese and Asian Indians.^[@bib33],\ [@bib34]^ Although our findings would appear to support this recommendation, we caution that these results are limited to older men in these specific ethnic groups.

Lastly, although there was no difference between Chinese and Asian Indians in the correlation between WC and IP-AT, WC was strongly correlated with RP-AT in Chinese but not Asian Indians. In other words, as both Chinese and Asian Indian men become increasingly centrally obese, Chinese men would store more fat in the RP-AT, but both groups would also store more fat in the IP-AT. It had been recently reported in our population that the relationship between WC or BMI and insulin resistance were not different between Chinese and Asian Indian men.^[@bib35]^ As IP-AT is the adipose depot that is more metabolically active as shown in other studies^[@bib36]^ (and consistent with our own findings that IP-AT was correlated with more metabolic markers than RP-AT), our findings support the notion that both the groups are at similar risk for DM and CVD at similar degrees of central obesity.

The strength of our study was that we had comprehensive data, including CT assessment for VAT with its IP-AT and RP-AT compartments, together with clinical and laboratory markers of obesity and cardiovascular disease. Singapore is a multi-racial country with a population that comprises 74.1% Chinese and 9.2% Asian Indians^[@bib37]^ that has seen a recent rapid increase in the rates of both DM^[@bib38]^ and cardiovascular mortality.^[@bib39]^ Similar trends have been observed in China and India,^[@bib40],\ [@bib41],\ [@bib42],\ [@bib43]^ two of the most populous countries in the world. As such, we believe our findings will have great relevance to other countries in Asia. However, the main limitation of our study was that our Chinese and Asian Indian subjects were rather different. The Chinese were mostly healthy, whereas most of the Asian Indians had one or more chronic diseases. As such, we would be cautious about extrapolating these results to a different population.

In conclusion, the L2-L3 intervertebral space was the best anatomic level for a single-slice CT cross-sectional area measurement of VAT to approximate total body visceral adipose volume in this population of Chinese and Asian Indian men older than 60 years. L2/3 VAT was better correlated with multiple cardiovascular risk factors, adipokines and inflammatory marker than either L4/5 VAT, WC or BMI.
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###### Baseline characteristics---mean (s.d.); *n* (%)

  *Characteristic*                                            *Chinese (*n*=60)*   *Asian Indian (*n*=60)*
  ----------------------------------------------------------- -------------------- -------------------------
  Age                                                         66.8 (4.7)           65.7 (7.0)
  Weight (kg)                                                 65.3 (14.5)          70.0 (13.5)
  Height (cm)                                                 164 (6)              165 (7)
  BMI                                                         24.1 (4.3)           26.3 (4.3)
  Waist circumference (cm)                                    84.7 (9.5)           88.5 (14.1)
  Hip circumference (cm)                                      89.1 (17.0)          92.7 (13.6)
  Waist--hip ratio                                            0.964 (0.105)        0.958 (0.094)
  L23 level VAT (mm3)                                         78 213 (36 599)      88 771 (41 980)
  Systolic BP (mm Hg)                                         136 (20)             134 (22)
  Diastolic BP (mm Hg)                                        79 (9.8)             76 (12)
  Resistin (ng ml^−1^)[a](#t1-fn1){ref-type="fn"}             10.2 (5.82)          7.79 (2.83)
  Leptin (μg l^−1^)[a](#t1-fn1){ref-type="fn"}                4.51 (2.65)          8.88 (6.13)
  Adiponectin (ng ml^−1^)                                     5999 (2992)          6465 (3755)
  Hs-CRP (mg l^−1^)[a](#t1-fn1){ref-type="fn"}                1.48 (1.74)          2.88 (3.32)
  Fasting glucose (mmol l^−1^)[a](#t1-fn1){ref-type="fn"}     5.43 (0.89)          6.57 (2.54)
  Fasting insulin (μU ml^−1^)                                 6.87 (6.22)          8.40 (4.45)
  HOMA-IR[a](#t1-fn1){ref-type="fn"}                          1.69 (1.72)          2.61 (2.27)
  Total cholesterol (mmol l^−1^)[a](#t1-fn1){ref-type="fn"}   5.39 (0.76)          4.87 (0.99)
  HDL-cholesterol (mmol l^−1^)[a](#t1-fn1){ref-type="fn"}     1.26 (0.27)          1.10 (0.22)
  Triglyceride (mmol l^−1^)                                   1.51 (0.85)          1.38 (0.72)
  LDL-cholesterol (mmol l^−1^)[a](#t1-fn1){ref-type="fn"}     3.45 (0.88)          3.13 (0.88)
  Hypertension on medication                                  0 (0%)               37 (62%)
  Diabetes on medication                                      0 (0%)               19 (32%)
  Hyperlipidemia on medication                                0 (0%)               20 (33%)

Abbreviations: BMI, body mass index; BP, blood pressure; CRP, C-reactive protein; HDL, high-density lipoprotein; HOMA-IR, homeostasis model assessment-insulin resistance; LDL, low-density lipoprotein; VAT, visceral adipose tissue.

Chinese and Asian Indian between group difference significant at *P*\<0.05.

The values presented in the above table represent mean (s.d.), except for the proportion of patients with hypertension, diabetes and hyperlipidemia on medications, for which the values represent *n* (%).

###### *R* ^2^ for correlation between VAT area and total VAT volume Chinese and Asian Indian

  *Level of VAT area*   R^*2*^ *between VAT area at that level and total VAT volume*   
  --------------------- -------------------------------------------------------------- -------
  T11/12                0.886                                                          0.682
  T12/L1                0.838                                                          0.854
  L1/L2                 0.967                                                          0.942
  L2/L3                 0.974                                                          0.946
  L3/L4                 0.952                                                          0.944
  L4/L5                 0.874                                                          0.641
  L5/S1                 0.785                                                          0.563

Abbreviation: VAT, visceral adipose tissue.

###### Linear regression beta and *P*-values between clinical and biochemical parameters and L23 VAT, L45 VAT and waist, with or without adjustment for BMI

                          *L23 VAT (β,* P)   *L45 VAT (β,* P)   *Waist (β,* P)   *BMI (β,* P)                                     
  ----------------------- ------------------ ------------------ ---------------- --------------- ---------------- --------------- ----------------
  Adjusted systolic BP    0.179, 0.054       0.091, 0.442       0.074, 0.431     −0.058, 0.954   0.131, 0.161     0.041, 0.383    0.202, 0.033
  Adjusted diastolic BP   0.163, 0.067       0.086, 0.448       0.012, 0.859     −0.070, 0.471   0.133, 0.138     0.057, 0557     0.181, 0.046
  Ln (fasting glucose)    0.420, \<0.001     0.420, \<0.001     0.185, 0.065     0.087, 0.424    0.405, \<0.001   0.370, 0.001    0.265, 0.008
  Ln (fasting insulin)    0.469, \<0.001     0.391, 0.001       0.197, 0.050     0.044, 0.676    0.397, \<0.001   0.279, 0.012    0.373, \<0.001
  Ln (HOMA-IR)            0.521, \<0.001     0.451, \<0.001     0.221, 0.027     0.060, 0.559    0.453, \<0.001   0.339, 0.002    0.398, \<0.001
  HDL-c                   −0.250, 0.008      −0.234, 0.045      −0.173, 0.073    −0.126, 0.235   −0.250, 0.009    −0.223, 0.041   −0.167, 0.087
  Ln (TG)                 0.219, 0.030       0.342, 0.006       0.225, 0.027     0.279, 0.013    0.208, 0.040     0.283, 0.015    −0.011, 0.916
  Ln (leptin)             0.425, \<0.001     0.241, 0.008       0.220, 0.008     0.054, 0.495    0.419, \<0.001   0.261, 0.002    0.456, \<0.001
  Ln (adiponectin)        −0.343, \<0.001    −0.288, 0.011      −0.181, 0.054    −0.091, 0.359   −0.272, 0.003    −0.185, 0.076   −0.272, 0.004
  Ln (hs-CRP)             0.259, 0.003       0.180, 0.106       0.073, 0.418     −0.027, 0.781   0.210, 0.018     0.119, 0.240    0.244, 0.007

Abbreviations: BP, blood pressure; HDL-c, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment-insulin resistance; Hs-CRP, highly sensitive C-reactive protein; TG, triglyceride; VAT, visceral adipose tissue.

Model 1: adjusted for age and race; Model 2: adjusted for age, race and BMI.

###### Linear regression beta and *P*-values between clinical and biochemical parameters and IP-AT, RP-AT at L2/3, with or without adjustment for BMI

                          *IP-AT (β,* P)    *RP-AT (β,* P)                     
  ----------------------- ----------------- ---------------- ----------------- ----------------
  Adjusted systolic BP    0.202, 0.032      0.125, 0.297     0.102, 0.276      0.007, 0.949
  Adjusted diastolic BP   0.155, 0.087      0.070, 0.543     0.148, 0.098      0.080, 0.430
  Ln (fasting glucose)    0.471, \<0.001    0.490, \<0.001   0.278, 0.005      0.192, 0.100
  Ln (fasting insulin)    0.413, \<0.001    0.296, 0.012     0.514, \<0.001    0.447, \<0.001
  Ln (HOMA-IR)            0.484, \<0.001    0.383, 0.001     0.527, \<0.001    0.446, \<0.001
  HDL-c                   −0.261, 0.007     −0.243, 0.038    −0.196, 0.040     −0.152, 0.171
  Ln (TG)                 0.243, 0.018      0.363, 0.003     0.144, 0.156      0.203, 0.086
  Ln (leptin)             0.410, \<0.001    0.208, 0.026     0.375, \<0.001    0.207, 0.012
  Ln (adiponectin)        −0.333, \<0.001   −0.267, 0.022    −0.294, \<0.001   −0.215, 0.037
  Ln (hs-CRP)             0.259, 0.004      0.175, 0.123     0.213, 0.017      0.126, 0.210

Abbreviations: BP, blood pressure; HDL-c, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model assessment-insulin resistance; Hs-CRP, highly sensitive C-reactive protein; IP-AT, intraperitoneal adipose tissue; RP-AT, retroperitoneal adipose tissue; TG, triglyceride.

Model 1: adjusted for age and race; Model 2: adjusted for age, race and BMI.
